{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:11:07Z","timestamp":1761102667316,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.anai.2023.01.004","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T05:01:46Z","timestamp":1680238906000},"page":"409-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of patient-reported outcome measures and inflammatory biomarkers to differentiate chronic rhinosinusitis with nasal polyp endotypes: Is it feasible?"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3476-1196","authenticated-orcid":false,"given":"Jonathan A.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2023.01.004_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.anai.2022.11.020","article-title":"Can patient reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?","volume":"130","author":"Plath","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.01.004_bib0002","doi-asserted-by":"crossref","unstructured":"Rank MA, Chu DK, Bognanni A, Oykhman P, Bernstein JA, Ellis AK, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis [e-pub ahead of print]. J Allergy Clin Immunol. doi:10.1016\/j.jaci.2022.10.026, accessed December 30, 2022.","DOI":"10.1016\/j.jaci.2022.10.026"},{"issue":"Suppl S29","key":"10.1016\/j.anai.2023.01.004_bib0003","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.anai.2023.01.004_bib0004","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jaci.2020.11.037","article-title":"Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps","volume":"147","author":"Klingler","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.01.004_bib0005","doi-asserted-by":"crossref","unstructured":"Wang X, Sima Y, Zhao Y, Zhang N, Zheng M, Du K, et al. Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors [e-pub ahead of print]. J Allergy Clin Immunol. doi:10.1016\/j.jaci.2022.10.010, accessed December 30, 2022.","DOI":"10.1016\/j.jaci.2022.10.010"},{"issue":"4","key":"10.1016\/j.anai.2023.01.004_bib0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.14639\/0392-100X-N1800","article-title":"Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP","volume":"42","author":"De Corso","year":"2022","journal-title":"Acta Otorhinolaryngol Ital"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:31:15Z","timestamp":1761053475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1081120623000091"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.004","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of patient-reported outcome measures and inflammatory biomarkers to differentiate chronic rhinosinusitis with nasal polyp endotypes: Is it feasible?","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.11.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}